Astrocyte ablation induced by La-aminoadipate (L-AAA) potentiates remyelination in a cuprizone demyelinating mouse model

Acs P, Kipp M, Norkute A, Johann S, Clarner T, Braun A, Berente Z, Komoly S, Beyer C (2009) 17β-estradiol and progesterone prevent cuprizone provoked demyelination of corpus callosum in male mice. Glia 57(8):807–814

Aryanpour R, Pasbakhsh P, Zibara K, Namjoo Z, Boroujeni FB, Shahbeigi S, Kashani IR, Beyer C, Zendehdel A (2017) Progesterone therapy induces an M1 to M2 switch in microglia phenotype and suppresses NLRP3 inflammasome in a cuprizone-induced demyelination mouse model. Int Immunopharmacol 51:131–139

Back SA, Tuohy TM, Chen H, Wallingford N, Craig A, Struve J, Luo NL, Banine F, Liu Y, Chang A (2005) Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation. Nat Med 11(9):966–972

Baron W, Colognato H, Ffrench-Constant C (2005) Integrin-growth factor interactions as regulators of oligodendroglial development and function. Glia 49(4):467–479

Bianchi R, Kastrisianaki E, Giambanco I, Donato R (2011) S100B protein stimulates microglia migration via RAGE-dependent up-regulation of chemokine expression and release. J Biol Chem 286(9):7214–7226

Biber K, Dijkstra I, Trebst C, De Groot C, Ransohoff R, Boddeke H (2002) Functional expression of CXCR3 in cultured mouse and human astrocytes and microglia. Neuroscience 112(3):487–497

Chang A, Tourtellotte WW, Rudick R, Trapp BD (2002) Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N Engl J Med 346(3):165–173

Chari D, Huang W, Blakemore W (2003) Dysfunctional oligodendrocyte progenitor cell (OPC) populations may inhibit repopulation of OPC depleted tissue. J Neurosci Res 73(6):787–793

Clemente D, Ortega MC, Melero-Jerez C, De Castro F (2013) The effect of glia-glia interactions on oligodendrocyte precursor cell biology during development and in demyelinating diseases. Front Cell Neurosci 7:268

Correale J, Farez MF (2015) The role of astrocytes in multiple sclerosis progression. Front Neurol 6:180

D’haeseleer M, Beelen R, Fierens Y, Cambron M, Vanbinst A-M, Verborgh C, Demey J, De Keyser J (2013) Cerebral hypoperfusion in multiple sclerosis is reversible and mediated by endothelin-1. Proc Natl Acad Sci USA 110(14):5654–5658

Foale S, Berry M, Logan A, Fulton D, Ahmed Z (2017) LINGO-1 and AMIGO3, potential therapeutic targets for neurological and dysmyelinating disorders? Neural Regen Res 12(8):1247

Franklin RJ, Kotter MR (2008) The biology of CNS remyelination. J Neurol 255(1):19–25

Frohman EM, Racke MK, Raine CS (2006) Multiple sclerosis—the plaque and its pathogenesis. N Engl J Med 354(9):942–955

Gadea A, Aguirre A, Haydar TF, Gallo V (2009) Endothelin-1 regulates oligodendrocyte development. J Neurosci 29(32):10047–10062

Ghareghani M, Ghanbari A, Dokoohaki S, Farhadi N, Hosseini SM, Mohammadi R, Sadeghi H (2016) Methylprednisolone improves lactate metabolism through reduction of elevated serum lactate in rat model of multiple sclerosis. Biomed Pharmacother 84:1504–1509

Gochenauer GE, Robinson MB (2001) Dibutyryl-cAMP (dbcAMP) up-regulates astrocytic chloride-dependent l-[3H] glutamate transport and expression of both system xc− subunits. J Neurochem 78(2):276–286

Hammond TR, Gadea A, Dupree J, Kerninon C, Nait-Oumesmar B, Aguirre A, Gallo V (2014) Astrocyte-derived endothelin-1 inhibits remyelination through notch activation. Neuron 81(3):588–602

Hammond TR, McEllin B, Morton PD, Raymond M, Dupree J, Gallo V (2015) Endothelin-B receptor activation in astrocytes regulates the rate of oligodendrocyte regeneration during remyelination. Cell Rep 13(10):2090–2097

John GR, Shankar SL, Shafit-Zagardo B, Massimi A, Lee SC, Raine CS, Brosnan CF (2002) Multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation. Nat Med 8(10):1115–1121

Karussis D, Karageorgiou C, Vaknin-Dembinsky A, Gowda-Kurkalli B, Gomori JM, Kassis I, Bulte JW, Petrou P, Ben-Hur T, Abramsky O (2010) Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. Arch Neurol 67(10):1187–1194

Khurgel M, Koo AC, Ivy GO (1996) Selective ablation of astrocytes by intracerebral injections of α-aminoadipate. Glia 16(4):351–358

Kieseier BC, Stüve O (2011) A critical appraisal of treatment decisions in multiple sclerosis—old versus new. Nat Rev Neurol 7(5):255–262

Kipp M, Clarner T, Dang J, Copray S, Beyer C (2009) The cuprizone animal model: new insights into an old story. Acta Neuropathol 118(6):723–736

Ko EM, Ma JH, Guo F, Miers L, Lee E, Bannerman P, Burns T, Ko D, Sohn J, Soulika AM (2014) Deletion of astroglial CXCL10 delays clinical onset but does not affect progressive axon loss in a murine autoimmune multiple sclerosis model. J Neuroinflammation 11(1):105

Li Z-W, Tang R-H, Zhang J-P, Tang Z-P, Qu W-S, Zhu W-H, Li J-J, Xie M-J, Tian D-S, Wang W (2011) Inhibiting epidermal growth factor receptor attenuates reactive astrogliosis and improves functional outcome after spinal cord injury in rats. Neurochem Int 58(7):812–819

McKhann GM (1982) Guillain-Barré syndrome is there a role for plasmapheresis? An update. Neurology 32(11):1282–1282

Nair A, Frederick TJ, Miller SD (2008) Astrocytes in multiple sclerosis: a product of their environment. Cell Mol Life Sci 65(17):2702–2720

Nessler J, Bénardais K, Gudi V, Hoffmann A, Tejedor LS, Janßen S, Prajeeth CK, Baumgärtner W, Kavelaars A, Heijnen CJ (2013) Effects of murine and human bone marrow-derived mesenchymal stem cells on cuprizone induced demyelination. PLoS One 8(7):e69795

Nishimura R, Santos D, Fu S-T, Dwyer B (2000) Induction of cell death by L-alpha-aminoadipic acid exposure in cultured rat astrocytes: relationship to protein synthesis. Neurotoxicology 21(3):313–320

Qin H, Benveniste EN (2012) ELISA methodology to quantify astrocyte production of cytokines/chemokines in vitro. Methods Mol Biol 814:235–249

Ransohoff RM, Hamilton TA, Tani M, Stoler MH, Shick HE, Major JA, Estes ML, Thomas DM, Tuohy VK (1993) Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis. FASEB J 7(6):592–600

Rappert A, Bechmann I, Pivneva T, Mahlo J, Biber K, Nolte C, Kovac AD, Gerard C, Boddeke HW, Nitsch R (2004) CXCR3-dependent microglial recruitment is essential for dendrite loss after brain lesion. J Neurosci 24(39):8500–8509

Skripuletz T, Gudi V, Hackstette D, Stangel M (2011) De-and remyelination in the CNS white and grey matter induced by cuprizone: the old, the new, and the unexpected. Histol Histopathol 26(12):1585–1597

Skripuletz T, Hackstette D, Bauer K, Gudi V, Pul R, Voss E, Berger K, Kipp M, Baumgärtner W, Stangel M (2012) Astrocytes regulate myelin clearance through recruitment of microglia during cuprizone-induced demyelination. Brain 136(1):147–167

Stoffels JM, de Jonge JC, Stancic M, Nomden A, van Strien ME, Ma D, Šišková Z, Maier O, Ffrench-Constant C, Franklin RJ (2013) Fibronectin aggregation in multiple sclerosis lesions impairs remyelination. Brain 136(1):116–131

Stoffels JM, Hoekstra D, Franklin RJ, Baron W, Zhao C (2015) The EIIIA domain from astrocyte-derived fibronectin mediates proliferation of oligodendrocyte progenitor cells following CNS demyelination. Glia 63(2):242–256

Tanuma N, Sakuma H, Sasaki A, Matsumoto Y (2006) Chemokine expression by astrocytes plays a role in microglia/macrophage activation and subsequent neurodegeneration in secondary progressive multiple sclerosis. Acta Neuropathol 112(2):195–204

Tsai MJ, Chang Y-F, Schwarcz R, Brookes N (1996) Characterization ofl-α-aminoadipic acid transport in cultured rat astrocytes. Brain Res 741(1–2):166–173

Voskuhl RR, Peterson RS, Song B, Ao Y, Morales LBJ, Tiwari-Woodruff S, Sofroniew MV (2009) Reactive astrocytes form scar-like perivascular barriers to leukocytes during adaptive immune inflammation of the CNS. J Neurosci 29(37):11511–11522

Williams A, Piaton G, Aigrot M-S, Belhadi A, Théaudin M, Petermann F, Thomas J-L, Zalc B, Lubetzki C (2007a) Semaphorin 3A and 3F: key players in myelin repair in multiple sclerosis? Brain 130(10):2554–2565

Williams A, Piaton G, Lubetzki C (2007b) Astrocytes—friends or foes in multiple sclerosis? Glia 55(13):1300–1312

Yamamoto S, Gotoh M, Kawamura Y, Yamashina K, Yagishita S, Awaji T, Tanaka M, Maruyama K, Murakami-Murofushi K, Yoshikawa K (2014) Cyclic phosphatidic acid treatment suppress cuprizone-induced demyelination and motor dysfunction in mice. Eur J Pharmacol 741:17–24

Zhang Y, Argaw AT, Gurfein BT, Zameer A, Snyder BJ, Ge C, Lu QR, Rowitch DH, Raine CS, Brosnan CF (2009) Notch1 signaling plays a role in regulating precursor differentiation during CNS remyelination. Proc Natl Acad Sci USA 106(45):19162–19167